17.01.2014 • NewsCarlylehepatitis CHIV

Carlyle Wins J&J Diagnostic Unit

As expected, U.S. private equity investor Carlyle has been given the nod to acquire the ortho clinical diagnostics unit of compatriot pharmaceutical producer Johnson & Johnson (J&J). The selling price of $4.15 billion was in line with analysts' estimates. Carlyle said it plans to close the deal by the middle of this year. The business, a small player in a market dominated by larger companies, manufactures blood-screening equipment and laboratory blood tests as well as tests capable of identifying blood types and screening for viruses such as HIV and hepatitis C. J&J announced at the beginning of 2013 that it was exploring strategic alternatives for the activities.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.